Streetbeat News

Equity Actions

BAC

Bank of America (NYSE:BAC) has received mixed analyst ratings over the past three months, with 7 analysts offering a range of opinions. The average 12-month price target is $40.56, up from $39.00, with high and low estimates of $51.00 and $30.00 respectively. Analysts from firms including Barclays, Odeon Capital, Goldman Sachs, Oppenheimer, Keefe, Bruyette & Woods, and BMO Capital have adjusted their ratings and price targets, reflecting their views on the company's market performance and financial health. Bank of America, a major U.S. financial institution, shows a positive revenue trend, strong net margin, but below industry average ROE and ROA, and a prudent debt management strategy.

Portfolio Pulse from Benzinga Insights

January 02, 2024 | 12:00 pm

COF

Over the past three months, 10 analysts have provided diverse ratings for Capital One Financial (NYSE:COF), with an average 12-month price target of $118.3, up from $116. The ratings range from bullish to bearish, with recent actions including both upgrades and downgrades. Capital One is a large financial services company with strong revenue growth, net margin, and ROE, but a lower ROA and conservative debt management. Analysts' ratings and price targets reflect their views on the company's performance and market conditions.

Portfolio Pulse from Benzinga Insights

January 02, 2024 | 12:00 pm

MNKD

MannKind Corporation has entered into a deal to sell a 1% royalty on net sales of Tyvaso DPI, a treprostinil inhalation powder, for up to $200 million. This includes an upfront purchase price of $150 million and an additional potential milestone payment of up to $50 million.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 11:10 am

VFS

Vinfast Auto has announced that an unnamed buyer will purchase a convertible debenture with a principal amount of $50 million, as reported in a 6-K filing.

Portfolio Pulse from Charles Gross

January 02, 2024 | 11:06 am

IBRX

ImmunityBio, Inc. has secured a $320 million investment from Oberland Capital. This investment is part of a larger financing strategy that has brought the total funds raised by ImmunityBio in 2023 to $850 million. The capital infusion is expected to support the company's ongoing research and development efforts.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 11:03 am

DANOY

Danone SA has agreed to sell its U.S. premium organic dairy activity, including Horizon Organic and Wallaby, to Platinum Equity. This move is part of Danone's Renew Danone strategy, focusing on health-focused brands and asset rotation. The U.S. organic dairy segment accounted for 3% of Danone's global revenues and had a dilutive effect on sales growth and margin. Danone will keep a minority stake post-sale. DANOY shares closed slightly up at $12.95.

Portfolio Pulse from Lekha Gupta

January 02, 2024 | 10:44 am

MO

Juul directors Nick Pritzker and Riaz Valani orchestrated a bailout of the vaping company in 2022. During that time, Juul's CEO and General Counsel raised internal concerns about potential conflicts of interest involving Pritzker and Valani. The Wall Street Journal reported this information citing sources familiar with the matter. Altria Group Inc. (MO), which has a stake in Juul, may be indirectly affected by these developments.

Portfolio Pulse from Charles Gross

January 02, 2024 | 10:33 am

CNHI

CNH Industrial N.V. (NYSE:CNHI) has completed the voluntary delisting of its shares from Euronext Milan. The company's shares are now exclusively listed on the New York Stock Exchange (NYSE).

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 10:04 am

CALM

LMDX

PALI

SPGC

WNW

Several companies are in focus heading into Tuesday with key developments: Sacks Parente Golf, Inc. (SPGC) announced the immediate resignation of its CEO, with shares dropping in after-hours trading. LumiraDx Limited (LMDX) agreed to sell its technology platform to Roche, resulting in a share price decline. Palisade Bio, Inc. (PALI) filed for a common stock offering, slightly boosting its share price. Meiwu Technology Co., Limited (WNW) reported a significant revenue surge and a decrease in net loss, leading to a share price increase. Cal-Maine Foods, Inc. (CALM) plans to acquire assets from Tyson Foods, with a slight decrease in its share price after the announcement.

Portfolio Pulse from Avi Kapoor

January 02, 2024 | 7:44 am

FBIO

FSR

The CNN Money Fear and Greed index indicates 'Extreme Greed' despite a slight decline in market sentiment. The S&P 500 surged 24.2% in 2023, marking its best streak since 2004. Fisker Inc. (FSR) shares rose 16% after a business update, while Fortress Biotech, Inc. (FBIO) shares dropped over 22% due to a direct offering announcement. The Dow Jones and Nasdaq also saw gains in 2023, with the latter recording its best year since 2020.

Portfolio Pulse from Avi Kapoor

January 02, 2024 | 7:32 am